Riley Antony A
Chief Financial Officer | Chief Financial Officer
2 companies
Insider Signal Score
65
GoodTrades Analyzed
3
12M Win Rate
100.0%
Avg 3M Return
+3.6%
Avg 12M Return
+43.1%
Riley Antony A is a Chief Financial Officer at Forte Biosciences, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 5 buys and 2 sells.
Estimated insider holdings value: $3.9M based on current market prices.
Holdings by Company
Transaction History
Showing 5 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | FBRX Forte Biosciences, Inc. | Chief Financial Officer | Buy | 9,680 | $26.33 | $254,832.78 | +30.4% | +0.2% | - | |
| Nov 21, 2024 | FBRX Forte Biosciences, Inc. | Chief Financial Officer | Buy | 22,514 | $5.55 | $124,997.73 | +272.5% | -36.0% | +17.7% | |
| Sep 7, 2021 | FBRX Forte Biosciences, Inc. | Chief Financial Officer | Sell | 25,000 | $4.24 | $106,105.48 | -49.4% | -46.5% | -68.5% | |
| Jun 29, 2020 | FBRX Forte Biosciences, Inc. | Chief Financial Officer | Buy | 6,700 | $14.39 | $96,445.20 | +10.6% | - | - | |
| May 22, 2018 | KRYS Krystal Biotech, Inc. | Chief Financial Officer | Buy | 2,800 | $10.75 | $30,100.00 | New | - | - |